Abstract:Natural killer (NK) cells play a crucial role in antitumoral and antiviral responses. Yet, cancer cells can alter themselves or the microenvironment through the secretion of cytokines or other factors, hindering NK cell activation and promoting a less cytotoxic phenotype. These resistance mechanisms, often referred to as the "hallmarks of cancer" are significantly influenced by the activation of oncogenes, impacting most, if not all, of the described hallmarks. Along with oncogenes, other types of genes, the tumor suppressor genes are frequently mutated or modified during cancer. Traditionally, these genes have been associated with uncontrollable tumor growth and apoptosis resistance. Recent evidence suggests oncogenic mutations extend beyond modulating cell death/proliferation programs, influencing cancer immunosurveillance. While T cells have been more studied, the results obtained highlight NK cells as emerging key protagonists for enhancing tumor cell elimination by modulating oncogenic activity. A few recent studies highlight the crucial role of oncogenic mutations in NK cell-mediated cancer recognition, impacting angiogenesis, stress ligands, and signaling balance within the tumor microenvironment. This review will critically examine recent discoveries correlating oncogenic mutations to NK cell-mediated cancer immunosurveillance, a relatively underexplored area, particularly in the era dominated by immune checkpoint inhibitors and CAR-T cells. Building on these insights, we will explore opportunities to improve NK cell-based immunotherapies, which are increasingly recognized as promising alternatives for treating low-antigenic tumors, offering significant advantages in terms of safety and manufacturing suitability.

Mechanism of tumor cells escaping from immune surveillance of NK cells

Natural killer cells in cancer biology and therapy

Immune Evasion and Therapeutic Opportunities Based on Natural Killer Cells.

Escape of tumor cells from the NK cell cytotoxic activity

Natural killer group 2D receptor and its ligands in cancer immune escape

Natural killer cells in cancer immunotherapy

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy

NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances

Tumors Evade Immune Cytotoxicity by Altering the Surface Topology of NK Cells

Regulation of NK Cell Activation by Stimulatory and Inhibitory Receptors in Tumor Escape from Innate Immunity

Targeting Natural Killer Cells for Tumor Immunotherapy

NK cells are never alone: crosstalk and communication in tumour microenvironments

Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies

Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?

The mechanisms of tumor immune escape and the strategies of clinical treatment

Exploiting NK Cell Surveillance Pathways for Cancer Therapy

In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors

Natural Killer Cells: Tumor Surveillance and Signaling

Immune Checkpoint Molecules in Natural Killer Cells As Potential Targets for Cancer Immunotherapy.

A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review)